MedTrace Logo

Study to Compare the Pharmacokinetics Profiles of Four Racecadotril Products

NCT01476683 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-07-10

No results posted yet for this study

Summary

This study is designed to compare the pharmacokinetics of four products used for treatment of acute diarrhea.

Conditions

Interventions

DRUG

Racecadotril

Film-coated tablet

DRUG

Racecadotril

Racecadotril Powder Blend

DRUG

Racecadotril

Marketed Capsule

DRUG

Racecadotril

Marketed Film-coated Tablet

Sponsors & Collaborators

  • McNeil AB

    lead INDUSTRY

Principal Investigators

  • Elisabeth Kruse, PhD · McNeil AB

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01476683 on ClinicalTrials.gov